|
Post by seanismorris on Nov 9, 2015 11:20:30 GMT -5
The spirometer requirement is here to stay. Improving the Label should have started after Sanofi signed the partner agreement. They said they were in discussions with the FDA... This is all on Sanofi and I can't find anywhere that says they are doing anything to improve the Label.
The fact that MannKind ended up paying off the debt with cash is not a good sign. Someone looked at the books and had a discussion about the plan and decided MannKind was to high of a risk. This "someone" had a lot more information than is available to investors...
All indicators are saying run, and yet I'm still sitting here looking for anything that suggests MannKind is going to survive.
The call better be amazing otherwise the discussion is going to turn to "how best to Short MNKD" to get our money back.
Note: Al won't be on the call
|
|
|
Post by kball on Nov 9, 2015 11:25:36 GMT -5
I'm going with spiro option # 2 I think the problem is MannKind lacks a CEO, and has an incompetent board. OK, maybe I should stop there otherwise I'll be using "incompetent" too many times in a sentence... Excuse me while I get out my thesaurus. If it is option two then we need an activist investor to shake this company up and replace the management team. We have a good product. We need a partner who is going to market it. I do believe that that partner is the current one. But I do think that we need to have more PR from the company . Preferred stock offering to angel investor (like gs and B of A gave Warren during financial crises?)
|
|
|
Post by parrerob on Nov 9, 2015 11:27:52 GMT -5
falconquest, Spiro doesn't know about the SEC stuff, but either there is something going on in the background or MnKD.s management is the most incompetent, bungling, inept and blundering group in the history of Biotech stocks. Spiro here, Siberia is getting closer
Guys Spiro is more then right, there.
This time there is no way to think differently. Our management decided to left our "car" in the racing-market for 6.5 hours, without fuel to run and without info about the plan to make fuel. (And what is happening to PPS today is coming from beeing in the race without fuel),
Or they are totally incompetent ! Or there is something in the background .....
|
|
|
Post by peppy on Nov 9, 2015 11:28:36 GMT -5
There is so much money looking for a home. still think 5,000 patients = 7 million for mankind multiply that by 4 20,000 patients = 28 million. Direct mailing has started. as posted on another thread. all systems are go. physicians ready. coverage glass only half full, but not empty. There is plenty of money out there. All central banks have been printing.
|
|
|
Post by regulus on Nov 9, 2015 11:33:33 GMT -5
If it is option two then we need an activist investor to shake this company up and replace the management team. We have a good product. We need a partner who is going to market it. I do believe that that partner is the current one. But I do think that we need to have more PR from the company . Preferred stock offering to angel investor (like gs and B of A gave Warren during financial crises?) Al will not give up control unless there is no other way to save his invention. It is why he retains a majority of stock ownership and why an activist would not be able to make any significant changes until his majority stake no longer exists. If enough shares are issued he could be diluted but it hasn't happened yet.
|
|
|
Post by seanismorris on Nov 9, 2015 11:50:43 GMT -5
On every call since Al stepped down as CEO:
Management has asked for more rope...they say they need it to make a bridge, but all they make is nooses.
---
Everyone here knows about Afrezza's sky high potential (to reply to the other poster). The question is twofold, is there enough cash to get us there and is there the leadership (at MannKind & Sanofi) to make it happen.
Since the launch of Afrezza the answer to the second has been no, and now the first is also looking like a no.
We (the investors) have been able to take solace that even if Afrezza turned out to be a niche drug there was a promising pipeline (though we lacked the details). The reason (for solace) was we had the cash to develop the pipeline...now with the cash situation we (apparently) don't.
|
|
|
Post by afrizzle on Nov 9, 2015 14:47:02 GMT -5
I'm in deep like many here but I'm not ready to mutiny. I do wish management was more communicative but resist the urge to fill in the blanks on what "must" be going on. We don't know because they haven't told us but this doesn't mean things are good or bad.
If we're speculating, I'd just as well imagine that the next milestone is based on the 2nd commercial country of release and those in the know expect millions to be immediately available because of Israel (or maybe it's when EU is filed or approved and that money is coming any minute)
From the 1000 foot level I just don't believe Al would put a billion in then let it all go to crap over something easily handled as a short term loan.
|
|